Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,537.4
9.0 (0.36%)

 

  • STI Straits Times Index
    2,537.4
    9.0 (0.36%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,494.6
    -4.2 (-0.28%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    24,918.8
    132.6 (0.54%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,278.0
    -34.5 (-1.04%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    23,516.6
    42.3 (0.18%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    5,112.2
    20.4 (0.40%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,104.8M
  • Value: 912.5M
  • Rise: 124
  • Fall: 150
  • Unch: 504

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Jiutian Chemical0.085-
Sembcorp Marine0.137-0.002
QT Vascular0.010+0.002
Spackman0.006-
Pan Asian0.047-
Singtel2.120+0.010
OEL0.019-
Mapletree Log Tr2.050-0.070
Suntec Reit1.460-0.010
Samko Timber0.037+0.001

World Indices

World Indices
Name Last Change
Nasdaq 10,672.3 +39.3
HSI 23,235.4 -75.7
HSCEI 9,302.6 -68.6
Jakarta 4,945.8 +103.0
Nikkei 225 23,204.6 +116.8
SSE Comp 3,219.4 -3.8
Shanghai A 3,374.1 -4.0
Shanghai B 247.4 +0.8
KOSPI 2,278.8 +6.1

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

CYTOSORBENTS CORP CYTOSORBENTS CORPORATION
Updated on 23 Oct 2020 (End of trading day)
Last (USD): 8.300 Change: +0.040 High: 8.390 Remarks: -
Change (%): +0.48 Low: 8.170
Open 8.280 Yesterday's Close 8.260000000000002
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 116,079 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -0.44640 Trailing EPS (USD) e -0.39747 NAV (USD) b 0.5636
PE a - Trailing PE f - Price / NAV b 14.7268
Dividend (USD) d - Cash In Hand (USD) g 0.8136 Issued & Paid-up Shares c 43,157,900
Dividend Yield (%) d - Price / Cash In Hand g 10.202 Treasury Shares h -
Market Cap (M) 358.211 Enterprise Value (M) 339.453
Piotroski F Score 1 Exchange Code CTSO Par Value ( $ ) n.a.
52 Weeks Volatility (%) 79.89 Free Float (%) 88.7
Sector & Industry Health Technology - Medical Specialties
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 05 Aug 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 13 Jul 2015.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference CYTOSORBENTS CORP NASDAQ 358.211 - - 14.7268 -
Industry Medical Specialties NASDAQ 2,783.877 926.704 193.640 9.0411 0.031
Local Peer INTUITIVE SURGICAL INC NASDAQ 86,459.351 62.684 82.100 9.3391 -
Local Peer DEXCOM INC NASDAQ 39,350.044 389.219 192.233 29.0642 -
Local Peer ALIGN TECHNOLOGY INC NASDAQ 36,995.083 83.553 21.284 12.1956 -
Local Peer IDEXX LABORATORIES INC NASDAQ 36,544.602 85.441 79.428 133.8797 -
Local Peer GENMAB AS SPON ADS EACH REP 0.1 ORD SHS NASDAQ 23,363.279 71.953 27.927 8.6755 -
Local Peer HOLOGIC INC NASDAQ 17,587.671 - 26.640 7.7990 -
Local Peer INSULET CORPORATION NASDAQ 16,372.578 1,411.455 901.971 29.0654 -
Local Peer MASIMO CORPORATION NASDAQ 13,449.646 68.545 60.520 10.0031 -
Local Peer ABIOMED INC NASDAQ 12,677.211 62.447 79.895 11.5054 -
Local Peer NOVOCURE LTD NASDAQ 12,512.033 - 1,060.611 46.7180 -
Local Peer DENTSPLY SIRONA INC NASDAQ 10,739.078 40.848 - 2.3129 0.773
Local Peer QUIDEL CORP NASDAQ 10,412.434 142.791 67.309 17.0219 -
Other Local Peers TANDEM DIABETES CARE INC (NASDAQ), BRUKER CORPORATION (NASDAQ), IRHYTHM TECHNOLOGIES INC (NASDAQ), INTEGRA LIFESCIENCES HLDGS CORP (NASDAQ), ICU MEDICAL INC (NASDAQ), WRIGHT MEDICAL GROUP NV (NASDAQ), NEOGEN CORP (NASDAQ), STAAR SURGICAL CO (NASDAQ), INARI MEDICAL INC (NASDAQ), MERIT MEDICAL SYSTEMS (NASDAQ), NUVASIVE INC (NASDAQ), LIVANOVA PLC (NASDAQ), SHOCKWAVE MEDICAL INC (NASDAQ), CAREDX INC (NASDAQ), SILK ROAD MEDICAL INC (NASDAQ), OUTSET MEDICAL INC (NASDAQ), AXONICS MODULATION TECHNLOGS INC (NASDAQ), INOVIO PHARMACEUTICALS INC (NASDAQ), ATRICURE INC (NASDAQ), CARDIOVASCULAR SYSTEMS INC DEL (NASDAQ), BIOTELEMETRY INC (NASDAQ), INMODE LTD (NASDAQ), PULMONX CORPORATION (NASDAQ), MESA LABORATORIES INC (NASDAQ), NANO-X IMAGING LTD (NASDAQ), ATRION CORP (NASDAQ), HESKA CORP (NASDAQ), ORASURE TECHNOLOGIES INC (NASDAQ), CERUS CORP (NASDAQ), ORTHOPEDIATRICS CORP (NASDAQ), BIOLIFE SOLUTIONS INC (NASDAQ), VERICEL CORP (NASDAQ), LANTHEUS HOLDINGS INC (NASDAQ), GENMARK DIAGNOSTICS INC (NASDAQ), TACTILE SYSTEMS TECHNOLOGY INC (NASDAQ), ALPHATEC HLDGS INC (NASDAQ), ACUTUS MEDICAL INC (NASDAQ), SI BONE INC (NASDAQ), LEMAITRE VASCULAR INC (NASDAQ), ORTHOFIX MEDICAL INC (NASDAQ), CELLDEX THERAPEUTICS INC (NASDAQ), INOGEN INC (NASDAQ), NATUS MEDICAL INC (NASDAQ), ESTABLISHMENT LABS HLDGS INC (NASDAQ), ACCELERATE DIAGNOSTICS INC (NASDAQ), SURMODICS INC (NASDAQ), VAREX IMAGING CORPORATION (NASDAQ), AXOGEN INC (NASDAQ), AVITA THERAPEUTICS INC (NASDAQ), ZYNEX INC (NASDAQ), ANTARES PHARMA INC (NASDAQ), QUOTIENT LTD (NASDAQ), FLUIDIGM CORP DEL (NASDAQ), VIEWRAY INC (NASDAQ), ANGIODYNAMICS INC (NASDAQ), SEASPINE HOLDINGS CORP (NASDAQ), CUTERA INC (NASDAQ), TRANSMEDICS GROUP INC (NASDAQ), PROFOUND MED CORP (NASDAQ), OXFORD IMMUNOTEC GLOBAL PLC (NASDAQ), PULSE BIOSCIENCES INC (NASDAQ), AVADEL PHARMACEUTICALS PLC SPON ADR EACH REP 1 ORD SHS (NASDAQ), UTAH MEDICAL PRODUCTS (NASDAQ), ITAMAR MEDICAL LTD SPON ADS EACH REP 30 ORD SHS (NASDAQ), REPRO MEDSYSTEMS INC (NASDAQ), ACCURAY INCORPORATED (NASDAQ), IRADIMED CORP (NASDAQ), DERMTECH INC (NASDAQ), TELA BIO INC (NASDAQ), SIENTRA INC (NASDAQ), MISONIX INC (NASDAQ), APYX MEDICAL CORPORATION (NASDAQ), SOLITON INC (NASDAQ), ENLIVEX THERAPEUTICS LTD (NASDAQ), NYMOX PHARMACEUTICALS CORP(BAHAMAS) (NASDAQ), BIOSIG TECHNOLOGIES INC (NASDAQ), SURGALIGN HOLDINGS INC (NASDAQ), SOLENO THERAPEUTICS INC (NASDAQ), FONAR CORP (NASDAQ), INTRICOM CORP (NASDAQ), CLEARPOINT NEURO INC (NASDAQ), NEURONETICS INC (NASDAQ), VENUS CONCEPT INC (NASDAQ), CHEMBIO DIAGNOSTICS INC (NASDAQ), PAVMED INC (NASDAQ), DARIOHEALTH CORP (NASDAQ), ROCKWELL MEDICAL INC (NASDAQ), LENSAR INC (NASDAQ), NEMAURA MEDICAL INC (NASDAQ), BELLEROPHON THERAPEUTICS INC (NASDAQ), ELECTROCORE INC (NASDAQ), BRAINSWAY LTD SPON ADS EACH REP 2 ORD SHS (NASDAQ), NEPHROS INC (NASDAQ), BIOMERICA INC (NASDAQ), CONFORMIS INC (NASDAQ), TITAN MEDICAL INC (NASDAQ), TRINITY BIOTECH PLC ADR EACH REPR 4 CLS A ORD USD0.019 (NASDAQ), STRATA SKIN SCIENCES INC (NASDAQ), DELCATH SYSTEMS INC (NASDAQ), NEOVASC INC (NASDAQ), SENSUS HEALTHCARE INC (NASDAQ), COLLPLANT BIOTECHNOLOGIES LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), SINTX TECHNOLOGIES INC (NASDAQ), APPLIED UV INC (NASDAQ), IMMUCELL CORP (NASDAQ), APOLLO ENDOSURGERY INC (NASDAQ), HELIUS MEDICAL TECHNOLOGIES INC (NASDAQ), EKSO BIONICS HOLDINGS INC (NASDAQ), ZOSANO PHARMA CORP (NASDAQ), BIOLASE INC (NASDAQ), IRIDEX CORP (NASDAQ), NEUROTROPE INC (NASDAQ), MOTUS GI HOLDINGS INC (NASDAQ), REWALK ROBOTICS LTD (NASDAQ), AVINGER INC (NASDAQ), MEDIGUS SPON ADS EACH REP 50 ORD SHS (POST SPLT) (NASDAQ), CELSION CORPORATION (NASDAQ), AETHLON MEDICAL INC (NASDAQ), ALLIED HEALTHCARE PRODUCTS INC (NASDAQ), SECOND SIGHT MEDICAL PRODUCTS INC (NASDAQ), AKERS BIOSCIENCES INC (NASDAQ), ATOSSA THERAPEUTICS INC (NASDAQ), HANCOCK JAFFE LABORATORIES INC (NASDAQ), CHF SOLUTIONS INC (NASDAQ), CYANOTECH CORP (NASDAQ), THERMOGENESIS HOLDINGS INC (NASDAQ), CHECK-CAP LTD (NASDAQ), TENAX THERAPEUTICS INC (NASDAQ), DIGIRAD CORP (NASDAQ), MYOS RENS TECHNOLOGY INC (NASDAQ), PREDICTIVE ONCOLOGY INC (NASDAQ), LIANLUO SMART LIMITED (NASDAQ), DYNATRONICS CORP (NASDAQ), CANCER GENETICS INC (NASDAQ), NANOVIBRONIX INC (NASDAQ), VIVEVE MEDICAL INC (NASDAQ), OBALON THERAPEUTICS INC (NASDAQ), NEUROMETRIX INC (NASDAQ)
Global Peer ABBOTT LABORATORIES NYSE 190,845.429 52.058 56.952 - 1.219
Global Peer THERMO FISHER SCIENTIFIC INC NYSE 189,949.970 51.393 38.932 5.9688 0.160
Global Peer DANAHER CORP NYSE 165,276.313 66.408 53.057 4.7639 0.286
Global Peer MEDTRONIC PLC NYSE 149,794.162 31.279 33.952 2.9783 1.934
Global Peer STRYKER CORP NYSE 83,346.971 40.013 52.059 6.5350 0.959
Global Peer BECTON DICKINSON & CO NYSE 69,649.723 64.371 89.987 2.8997 1.196
Global Peer BOSTON SCIENTIFIC CORP NYSE 53,178.004 11.314 13.361 3.4053 -
Global Peer EDWARDS LIFESCIENCES CORP NYSE 49,994.194 47.755 62.957 11.8742 -
Global Peer KONINKLIJKE PHILIPS NV ADR EACH REP 1 ORD EUR0.20 NYSE 45,643.755 34.945 40.966 3.7106 1.825
Global Peer BAXTER INTERNATIONAL INC NYSE 41,050.353 41.009 44.427 5.0505 1.048
Other Global Peers AGILENT TECHNOLOGIES INC (NYSE), ALCON AG (NYSE), ZIMMER BIOMET HOLDINGS INC (NYSE), RESMED INC (NYSE), METTLER-TOLEDO INTERNATIONAL INC (NYSE), WEST PHARMACEUTICAL SERVICES INC (NYSE), COOPER COS INC (NYSE), BIO RAD LABORATORIES INC (NYSE), Top Glove (SGX), TOPGLOV (Bursa), TELEFLEX INC (NYSE), SMITH & NEPHEW ADR EACH REPR 2 ORD (NYSE), STERIS PLC (NYSE), VARIAN MEDICAL SYSTEMS INC (NYSE), HARTA (Bursa), PERKINELMER INC (NYSE), FISHER & PAYKEL HEALTHCARE CORP (ASX), WATERS CORP (NYSE), QIAGEN NV (NYSE), COCHLEAR LTD (ASX), WEIGAO GROUP (HKEx), PENUMBRA INC (NYSE), MICROPORT (HKEx), HILL-ROM HOLDINGS INC (NYSE), SUPERMX (Bursa), NEVRO CORP (NYSE), HAEMONETICS CORP (NYSE), GLOBUS MED INC (NYSE), ENVISTA HOLDINGS CORPORATION (NYSE), VENUS MEDTECH-B (HKEx), INSPIRE MEDICAL SYSTEMS INC (NYSE), KANGJI MEDICAL (HKEx), EBOS GROUP (ASX), AK MEDICAL (HKEx), GLAUKOS CORPORATION (NYSE), CONMED CORP (NYSE), PEIJIA-B (HKEx), CANTEL MEDICAL CORP (NYSE), AVANOS MEDICAL INC (NYSE), NANOSONICS LIMITED (ASX), CIRC (HKEx), LIFETECH SCI (HKEx), KDL MEDICAL (HKEx), VAPOTHERM INC (NYSE), CRYOLIFE INC (NYSE), INFUSYSTEM HOLDINGS INC (NYSE American), Medtecs Intl (SGX), UGHealthcare (SGX), MCP INCOME OPPORTUNITIES TRUST (ASX), YESTAR HEALTH (HKEx), CORMEDIX INC (NYSE American), PW MEDTECH (HKEx), AROA BIOSURGERY LTD (ASX), RETRACTABLE TECHNOLOGIES INC (NYSE American), VOLPARA HEALTH TECHNOLOGIES LTD (ASX), MEDICAL DEVELOPMENT INTL (ASX), STEREOTAXIS INC (NYSE American), INVACARE CORP (NYSE), ALPHA PRO TECH (NYSE American), MODERN DENTAL (HKEx), VINCENT MED (HKEx), EMVISION MEDICAL DEVICES LTD (ASX), SOMNOMED LIMITED (ASX), ATOMO DIAGNOSTICS LIMITED (ASX), CYCLOPHARM LIMITED (ASX), LKL (Bursa), RESPIRI LTD (ASX), VOLITIONRX LIMITED (NYSE American), ELECTROMED INC (NYSE American), SDI LTD (ASX), RESAPP HEALTH LIMITED (ASX), IMPEDIMED LIMITED (ASX), Biolidics (SGX), INCANNEX HEALTHCARE LTD (ASX), DAXOR CORP (NYSE American), MILESTONE SCIENTIFIC INC (NYSE American), COMPUMEDICS (ASX), MICRO-X LTD (ASX), ONCOCYTE CORP (NYSE American), RESONANCE HEALTH LTD (ASX), IMAGION BIOSYSTEMS LIMITED (ASX), OPTISCAN IMAGING (ASX), UNIVERSAL BIOSENSORS INC NPV (CDI) (ASX), KELFRED (HKEx), DIMERIX LTD (ASX), NOVA EYE MEDICAL LIMITED (ASX), LIFE HEALTH-NEW (HKEx), CARDIEX LTD (ASX), OSPREY MEDICAL INC NPV (CHESS DEPOSITARY INTERESTS) (ASX), Yunnan Energy (SGX), METALICITY LIMITED (ASX), OVENTUS MEDICAL LTD (ASX), XTANT MEDICAL HLDGS INC (NYSE American), LBT INNOVATIONS LTD (ASX), USCOM LTD (ASX), RA MEDICAL SYSTEMS INC (NYSE), Annica (SGX), ALLEGRA ORTHOPAEDICS LIMITED (ASX), ADHERIUM LIMITED (ASX), ANALYTICA (ASX), NEUROTECH INTERNATIONAL LTD (ASX), DORSAVI LTD (ASX), HUAKANG BIOMED (HKEx), INSPIREMD INC (NYSE American), MEDIGARD LIMITED (ASX), STHAI (SET)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --0.255
-2.98 %
10 Days -+0.080
+0.97 %
20 Days -+0.420
+5.33 %
Medium Term Return 3 Months --1.480
-15.13 %
6 Months --1.245
-13.04 %
1 Year -+3.600
+76.60 %
Long Term Return 2 Years --1.740
-17.33 %
3 Years -+2.100
+33.87 %
5 Years -+0.860
+11.56 %
Annualised Return Annualised --
+2.21 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 3.490 - 11.740 Change From 1 Year Low +4.810 % Change From 1 Year Low (%) +137.82
Change From 1 Year High -3.440 % Change From 1 Year High (%) -29.30
2 Years Range 3.490 - 12.000 Change From 2 Years Low +4.810 % Change From 2 Years Low (%) +137.82
Change From 2 Years High -3.700 % Change From 2 Years High (%) -30.83
5 Years Range 3.110 - 14.950 Change From 5 Years Low +5.190 % Change From 5 Years Low (%) +166.88
Change From 5 Years High -6.650 % Change From 5 Years High (%) -44.48
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

CytoSorbents Corp. engages in the critical care immunotherapy, investigation, and commercialization of blood purification technology. Its product portfolio include CytoSorb, ContrastSorb XL, HemoDefend, VetResQ, and DrugSorb. The company was founded by Joseph Rubin on April 25, 2002 and is headquartered in Monmouth Junction, NJ.

Historical Price Data

Date Open High Low Close Volume VWAP
23 Oct 2020 8.280 8.390 8.170 8.300 116,079 -
22 Oct 2020 8.040 8.310 7.870 8.260 288,981 -
21 Oct 2020 8.360 8.360 7.980 8.000 267,217 -
20 Oct 2020 8.480 8.710 8.280 8.370 234,346 -
19 Oct 2020 8.630 8.850 8.510 8.590 175,933 -
16 Oct 2020 8.440 8.590 8.400 8.555 188,872 -
15 Oct 2020 8.600 8.650 8.280 8.460 231,498 -
14 Oct 2020 8.850 9.390 8.620 8.650 387,297 -
13 Oct 2020 8.270 9.000 8.270 8.870 506,802 -
12 Oct 2020 8.190 8.450 8.130 8.290 178,333 -
09 Oct 2020 8.250 8.320 7.970 8.220 221,994 -
08 Oct 2020 8.430 8.440 8.060 8.090 157,819 -
07 Oct 2020 8.190 8.450 8.151 8.350 257,291 -
06 Oct 2020 8.100 8.340 8.065 8.110 199,390 -
05 Oct 2020 7.860 8.150 7.860 8.080 153,577 -
02 Oct 2020 7.820 7.970 7.660 7.860 197,392 -
01 Oct 2020 8.020 8.110 7.710 7.860 227,908 -
30 Sep 2020 8.100 8.240 7.890 7.975 207,124 -
29 Sep 2020 7.860 8.130 7.790 8.070 223,967 -
28 Sep 2020 7.920 8.000 7.810 7.870 171,299 -
25 Sep 2020 7.550 7.930 7.540 7.880 220,474 -
24 Sep 2020 7.720 7.820 7.510 7.570 323,105 -
Summary
Current 2 Weeks
(12 Oct 2020 to 23 Oct 2020)
8.190 9.390 7.870 8.300 2,575,358 -
Previous 2 Weeks
(28 Sep 2020 to 09 Oct 2020)
7.920 9.390 7.810 8.220 2,017,761 -
4 Weeks from
(28 Aug 2020 to 25 Sep 2020)
8.200 9.390 7.870 7.880 7,269,333 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.